Literature DB >> 11438653

Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation.

W K Miskimins1, G Wang, M Hawkinson, R Miskimins.   

Abstract

p27 is a key regulator of cell proliferation through inhibition of G(1) cyclin-dependent kinase (CDK) activity. Translation of the p27 mRNA is an important control mechanism for determining cellular levels of the inhibitor. Nearly all eukaryotic mRNAs are translated through a mechanism involving recognition of the 5' cap by eukaryotic initiation factor 4E (eIF4E). In quiescent cells eIF4E activity is repressed, leading to a global decline in translation rates. In contrast, p27 translation is highest during quiescence, suggesting that it escapes the general repression of translational initiation. We show that the 5' untranslated region (5'-UTR) of the p27 mRNA mediates cap-independent translation. This activity is unaffected by conditions in which eIF4E is inhibited. In D6P2T cells, elevated cyclic AMP levels cause a rapid withdrawal from the cell cycle that is correlated with a striking increase in p27. Under these same conditions, cap-independent translation from the p27 5'-UTR is enhanced. These results indicate that regulation of internal initiation of translation is an important determinant of p27 protein levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438653      PMCID: PMC87223          DOI: 10.1128/MCB.21.15.4960-4967.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

Review 1.  Signal transduction pathways that regulate eukaryotic protein synthesis.

Authors:  R E Rhoads
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

2.  The identification of an endonuclease that cleaves within an HuR binding site in mRNA.

Authors:  Z Zhao; F C Chang; H M Furneaux
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

3.  A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA.

Authors:  S S Millard; A Vidal; M Markus; A Koff
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

4.  Translation initiation factors induce DNA synthesis and transform NIH 3T3 cells.

Authors:  M R Smith; M Jaramillo; Y L Liu; T E Dever; W C Merrick; H F Kung; N Sonenberg
Journal:  New Biol       Date:  1990-07

5.  Internal initiation of translation mediated by the 5' leader of a cellular mRNA.

Authors:  D G Macejak; P Sarnow
Journal:  Nature       Date:  1991-09-05       Impact factor: 49.962

6.  Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs.

Authors:  M Kozak
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

7.  Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression.

Authors:  I Mothe-Satney; D Yang; P Fadden; T A Haystead; J C Lawrence
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

8.  Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F.

Authors:  R Duncan; S C Milburn; J W Hershey
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

9.  The mRNA 5' cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts.

Authors:  A Lazaris-Karatzas; N Sonenberg
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.

Authors:  J Pelletier; N Sonenberg
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

View more
  39 in total

1.  The major transcription initiation site of the p27Kip1 gene is conserved in human and mouse and produces a long 5'-UTR.

Authors:  J Coleman; M Hawkinson; R Miskimins; W K Miskimins
Journal:  BMC Mol Biol       Date:  2001-10-11       Impact factor: 2.946

Review 2.  Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites.

Authors:  S Vagner; B Galy; S Pyronnet
Journal:  EMBO Rep       Date:  2001-10       Impact factor: 8.807

3.  ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR.

Authors:  Michael Kullmann; Ulrich Göpfert; Basile Siewe; Ludger Hengst
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

4.  Begin at the beginning: predicting genes with 5' UTRs.

Authors:  Randall H Brown; Samuel S Gross; Michael R Brent
Journal:  Genome Res       Date:  2005-05       Impact factor: 9.043

Review 5.  Searching for IRES.

Authors:  Stephen D Baird; Marcel Turcotte; Robert G Korneluk; Martin Holcik
Journal:  RNA       Date:  2006-09-06       Impact factor: 4.942

6.  Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.

Authors:  Yi Cao; Zhefeng Zhao; Joanna Gruszczynska-Biegala; Anna Zolkiewska
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2.

Authors:  Martin Holcík; Bruce W Gordon; Robert G Korneluk
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

8.  Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.

Authors:  S Chu; T McDonald; R Bhatia
Journal:  Leukemia       Date:  2010-03-04       Impact factor: 11.528

9.  Upstream molecular signaling pathways of p27(Kip1) expression: effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids.

Authors:  Isao Eto
Journal:  Cancer Cell Int       Date:  2010-02-19       Impact factor: 5.722

10.  miR-181a regulates cap-dependent translation of p27(kip1) mRNA in myeloid cells.

Authors:  Rafael Cuesta; Aida Martínez-Sánchez; Fátima Gebauer
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.